The anti-apoptotic and anti-inflammatory properties of puerarin attenuate 3-nitropropionic-acid induced neurotoxicity in rats

被引:47
作者
Mahdy, Heba M. [1 ]
Mohamed, Mohamed R. [2 ]
Emam, Manal A. [2 ]
Karim, Amr M. [2 ]
Abdel-Naim, Ashraf [1 ]
Khalifa, Amani E. [1 ]
机构
[1] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt
[2] Ain Shams Univ, Dept Biochem, Fac Sci, Cairo, Egypt
关键词
Huntington's disease; puerarin; 3-nitropropionic acid; apoptosis; neuroinflammation; Nissl staining; ATP; FACTOR-KAPPA-B; TRAUMATIC BRAIN-INJURY; COMPLEX-II INHIBITION; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; STRIATAL DEGENERATION; PC12; CELLS; ACID MODEL; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE MECHANISMS;
D O I
10.1139/cjpp-2013-0398
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Puerarin (Pur), an isoflavonoid extracted from the dried roots of Pueraria lobata, has been reported to be useful in the treatment of various diseases. This study was designed to evaluate the anti-apoptotic and anti-inflammatory activities of Pur against 3-nitropropionic acid (3-NP) induced neurotoxicity. For 5 consecutive days, male Wistar rats were given Pur (200 mg/kg body mass) 30 min before treatment with 20 mg/kg body mass of 3-NP. The striata, hippocampi, and cortices of the 3-NP treated group showed apoptotic damage, inflammation, and energy deficit as well as histopathological lesions. The 3-NP-induced alteration in apoptotic biomarkers (caspase-3 activity/level, cytosolic cytochrome c, Bax/Bcl-2 levels) were significantly ameliorated by Pur treatment. Moreover, Pur pretreatment blocked 3-NP-induced inflammatory biomarkers (NF-kappa B, TNF-alpha, and iNOS) and prevented the energy deficit (ATP reduction). Nissl staining further confirmed Pur's neuroprotective effect. These results indicate that Pur may be a useful preventive approach to various neurodegenerative diseases with underlying apoptosis and neuroinflammation.
引用
收藏
页码:252 / 258
页数:7
相关论文
共 82 条
  • [1] Inflammatory and neurochemical changes associated with 3-nitropropionic acid neurotoxicity
    Ahuja, Manuj
    Chopra, Kanwaljit
    Bishnoi, Mahendra
    [J]. TOXICOLOGY MECHANISMS AND METHODS, 2008, 18 (04) : 335 - 339
  • [2] Modulation of apoptotic regulatory proteins and early activation of cytochrome C following systemic 3-nitropropionic acid administration
    Antonawich, FJ
    Fiore-Marasa, SM
    Parker, CP
    [J]. BRAIN RESEARCH BULLETIN, 2002, 57 (05) : 647 - 649
  • [3] Bancroft J.D., 1990, THEORY PRACTICE HIST, V3rd
  • [4] Bantubungi K, 2007, Rev Med Brux, V28, P413
  • [5] BEAL MF, 1993, J NEUROSCI, V13, P4181
  • [6] Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: Possible neuroprotective mechanisms
    Bhateja, Deepak Kumar
    Dhull, Dinesh K.
    Gill, Aneet
    Sidhu, Akramdeep
    Sharma, Saurabh
    Reddy, B. V. Krishna
    Padi, Satyanarayana S. V.
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 674 (01) : 33 - 43
  • [7] Organoselenium Bis Selenide Attenuates 3-Nitropropionic Acid-Induced Neurotoxicity in Rats
    Bortolatto, Cristiani F.
    Jesse, Cristiano R.
    Wilhelm, Ethel A.
    Chagas, Pietro M.
    Nogueira, Cristina W.
    [J]. NEUROTOXICITY RESEARCH, 2013, 23 (03) : 214 - 224
  • [8] Inflammation, neurodegenerative diseases, and environmental exposures
    Campbell, A
    [J]. PROTECTIVE STRATEGIES FOR NEURODEGENERATIVE DISEASES, 2004, 1035 : 117 - 132
  • [9] Neuroprotective effects of (±)-huprine Y on in vitro and in vivo models of excitoxicity damage
    Canudas, AM
    Pubill, D
    Sureda, FX
    Verdaguer, E
    Camps, P
    Muñoz-Torrero, D
    Jiménez, A
    Camins, A
    Pallàs, M
    [J]. EXPERIMENTAL NEUROLOGY, 2003, 180 (02) : 123 - 130
  • [10] CHAN ASC, 2006, Patent No. 2006042454